Ads

 

Ads

 

Ads

 

Basel Top Companies List by Market Cap as of January 2024

Basel Top Companies List by Market Cap as on Jan-05-2024. Biggest Basel Companies List by Market Cap in January 2024. Basel Largest Companies in January 2024.

Basel Top Companies by Market Cap in 2024
Basel Top Companies by Market Cap in 2024, Basel Largest Companies in 2024, Biggest Basel Companies by Market Cap.
  1. Roche Holding AG

    World Rank (Jan-05-2024)
    40
    Market Cap (Jan-05-2024)
    238.453 Billion USD
    World Rank (Jul-30-2023)
    38
    Market Cap (Jul-30-2023)
    249.730 Billion USD
    World Rank (Dec-25-2022)
    32
    Market Cap (Dec-25-2022)
    261.410 Billion USD
    World Rank (Jan-07-2022)
    25
    Market Cap (Jan-07-2022)
    356.15 Billion USD
    Annual Revenue in USD
    67,007 Million USD
    Annual Operating Income in USD
    17,067 Million USD
    Annual Net Income in USD
    12,747 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Roche Holding is  Healthcare Company having business in pharmaceuticals and diagnostics. The headquarters is in Switzerland. 

    Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Ophthalmology and Respiratory branches Medicines.

    Facts About Company

    Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

    Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

    As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

  2. Novartis AG

    World Rank (Jan-05-2024)
    45
    Market Cap (Jan-05-2024)
    216.513 Billion USD
    World Rank (Jul-30-2023)
    45
    Market Cap (Jul-30-2023)
    220.820 Billion USD
    World Rank (Dec-25-2022)
    47
    Market Cap (Dec-25-2022)
    195.460 Billion USD
    World Rank (Jan-07-2022)
    61
    Market Cap (Jan-07-2022)
    201.26 Billion USD
    Annual Revenue in USD
    46,660 Million USD
    Annual Operating Income in USD
    9,769 Million USD
    Annual Net Income in USD
    14,850 Million USD
    Annual Results for Period Ending
    Dec-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare.

    Facts About Company

    Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

    Novartis had over 101,703 employees worldwide as on 2022.

    Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

Share

Ads